| | Experimental host and age | Passage history and strain | Inoculation Route-Dose | Evidence of infection | AST (days) | Titer log10/ml | |
---|
|
| S-180 ascites tumor of mice destroyed by Piry virus, but virus titer potentiated (6). | Ponies, intralingual, elevated temp., ulcers at inoc. site; antibody production (8). | Steers, sheep, goats, intralingual, antibodies (8). | Pigs, inoc. in snout, heel, coronary band, antibodies (8). | | Mice (nb) | P-3 | ic 0.02 | Death | 1.3 | 10.7+ | | Mice (nb) | | ip 0.02 | Death | 1.7 | | | Mice (nb) | | sc | | | | | Mice (wn) | | ic 0.03 | Death | 3.8 | | | Mice (wn) | | ip 0.03 | Antibody | | >20.0 | | white rats (ad) | Prototype | ip 0.2 | Antibody | | | | guinea pigs (ad) | | ip 0.2 | Viremia, antibody | | | | hamsters (ad) | | ip 0.2 | Viremia, death | 2.5 | | | Didelphis, Philander(ad) | | im,sc 0.2 | Viremia, death | 4-12 | | |
| |
|